Precision Diagnostics Market Size to Hit US$ 182.79 Billion by 2031 | Growth Plus Reports

Newark, New Castle, USA, April 27, 2023 (GLOBE NEWSWIRE) -- A recent report by Growth Plus Reports estimated the global Precision Diagnostics Market to be worth US$ 12.30 billion in 2022. From 2023 to 2031, market revenue is expected to grow at a CAGR of 12.3%, reaching US$ 182.79 billion. The most successful strategies, market trends, the competitive environment, significant drivers and opportunities, statistical data, market size, and revenue are all included in the report. 

Key Takeaways: 

• The growing awareness regarding recent technological advancements is driving the global demand for precision diagnostics. 
• The market revenue growth is driven by numerous chronic disorders. 
• Continuous R&D activities are creating a strong product pipeline. 

Request Sample Copy of the Report:  https://www.growthplusreports.com/inquiry/request-sample/precision-diagnostics-market/8518

Precision Diagnostics Market Scope

Market Drivers: 
The growing technological advancements and digital solutions are accelerating the global market revenue for precision diagnostics. Additionally, the rising frequency of chronic disorders such as cancer and cardiovascular and neurological diseases is expected to contribute to the global market revenue during the forecast period. However, the high development cost and inaccurate diagnosis can restrain the market revenue growth.

Market Segmentation: 
Growth plus reports have analyzed the global precision diagnostics market from perspectives such as types, applications, and regions. 

Types Segmentation: 
Based on type, the global precision diagnostics market is segmented into esoteric tests, genetic tests, and others.
The genetic tests segment accounts for the largest revenue share in the global precision diagnostics market. This large revenue share is due to the increased awareness of early disease diagnosis and examination of DNA mutations or variations, and it helps in treatments and surgeries.  

Applications Segmentation: 
Based on application, the global precision diagnostics market is segmented into Cardiovascular, Oncology, Immunology, Neurology, and Others.
The oncology segment is expected to account for the largest revenue share in the global precision diagnostics market. This large revenue share is attributed to the molecular profiling of cancers for targeted therapies, diagnosing mutations and other genetic alterations that lead to cancer, and technological advancements in this field.

Regional Growth Dynamics: 
Based on region, the global precision diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and The Middle East & Africa.
North America accounts for the largest revenue share in the global precision diagnostics market. The market revenue is driven by the increasing demand for personalized medicine, the rising prevalence of chronic diseases, growing awareness about early disease detection and diagnosis, technological advancements, and the increasing focus on precision medicine. 

Request for Customization – https://www.growthplusreports.com/inquiry/customization/precision-diagnostics-market/8518

Competitive Landscape:
The prominent players operating in the global precision diagnostics market are: -

• Siemens Healthineers AG
• Abbott Laboratories
• Novartis AG
• Bluebird Bio, Inc.
• Quest Diagnostics 
• Qiagen NV
• Sanofi
• Bayer AG
• Quest Diagnostics Incorporated
• Swiss Precision Diagnostics GmbH

New product releases and higher R&D spending are two main techniques used by significant players to get a larger market revenue share. Both domestic and international companies in precision diagnostics are concentrating on launching unique products while expanding their R&D efforts and monitoring the entry of new competitors. 

Recent Developments:

• In March 2023, The Deerborne Group, a management consulting firm specializing in precision diagnostics, announced plans to broaden its network of independent consultants internationally and to provide a new selection of cutting-edge services.

• In March 2023, DnaNudge, the UK-based innovator of lab-free customer genetics testing and medical diagnostics solutions, announced an agreement with India's top biotech company Mylab Discovery Solutions, to develop next-generation molecular diagnostics for diabetic foot infections and other critical health conditions

• In February 2023, Cardio Diagnostics Holdings Inc.'s PrecisionCHD, the most recent coronary heart disease test, was presented at the American College of Cardiology's 72nd Annual Scientific Conference (ACC.23), which took place in New Orleans, Louisiana, in March 2023.

Table of Content

1. INTRODUCTION

1. 1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report

2. RESEARCH METHODOLOGY 

2. 1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions

3. PREMIUM INSIGHTS

3. 1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape

4. MARKET DYNAMICS

4. 1. Drivers
   2. Restraints/Challenges
   3. Opportunities

5. GLOBAL PRECISION DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY TYPE

5. 1. Esoteric Tests
   2. Genetic Tests
   3. Others

6. GLOBAL PRECISION DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY APPLICATION

6. 1. Cardiovascular
   2. Oncology
   3. Immunology
   4. Neurology 
   5. Others

PRECISION DIAGNOSTICS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8518

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse Latest Healthcare Related Reports:

IVD Contract Manufacturing Market by Type (IVD Consumables, IVD Equipments), by Services (Assay Development Services, Manufacturing Services, Others), Technology (Immunoassay, Clinical Diagnostics) – Global Outlook & Forecast 2023 -2031

Polypectomy Snares Market by Type (Cold Polypectomy Snares and Hot Polypectomy Snares), End User (Hospitals, Ambulatory Surgery Centers) – Global Outlook & Forecast 2023-2031

Golimumab Market by Indications (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), - Global Outlook and Forecast 2023-2031

Eosinophilic Fasciitis Market by Drug Class (Corticosteroids, Immunosuppressants), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Outlook and Forecast 2023-2031

Thymidine Phosphorylase Inhibitors Market by Application (Metastatic Colorectal Cancer, Gastric Cancer), Distribution Channel (Retail Pharmacies, Hospital Pharmacies) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.